Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
Julianna J. Tomlinson, Bojan Shutinoski, Li Dong, et al.
Journal of Neural Transmission (2017) Vol. 124, Iss. 6, pp. 721-738
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens
Zachary D. Wallen, Mary Appah, Marissa Dean, et al.
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 189
Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease
Luís M. A. Oliveira, Thomas Gasser, Robert H. Edwards, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 114
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Md Masud Alam, De Yang, Xiaoqing Li, et al.
Cell Reports (2022) Vol. 38, Iss. 2, pp. 110090-110090
Open Access | Times Cited: 78
How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology
Per Borghammer
Movement Disorders (2017) Vol. 33, Iss. 1, pp. 48-57
Closed Access | Times Cited: 124
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Penelope J. Hallett, Simone Engelender, Ole Isacson
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 90
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
Bojan Shutinoski, Mansoureh Hakimi, Irene E. Harmsen, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 511
Closed Access | Times Cited: 83
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Alysa Kasen, Christina Houck, Amanda R. Burmeister, et al.
Neurobiology of Disease (2022) Vol. 166, pp. 105654-105654
Open Access | Times Cited: 50
Inflammation in dementia with Lewy bodies
Jay Amin, Daniel Erskine, Paul C. Donaghy, et al.
Neurobiology of Disease (2022) Vol. 168, pp. 105698-105698
Open Access | Times Cited: 43
Prion-like propagation of pathology in Parkinson disease
Laura A. Volpicelli‐Daley, Patrik Brundin
Handbook of clinical neurology (2018), pp. 321-335
Open Access | Times Cited: 76
Olfactory dysfunction in the pathophysiological continuum of dementia
Praveen Bathini, Emanuele Brai, Lavinia Albéri
Ageing Research Reviews (2019) Vol. 55, pp. 100956-100956
Open Access | Times Cited: 62
Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
Ryan Limbocker, Silvia Errico, Denise Barbut, et al.
Natural Product Reports (2021) Vol. 39, Iss. 4, pp. 742-753
Open Access | Times Cited: 44
Who Ever Said It Would Be Easy? Reflecting on Two Clinical Trials Targeting α‐Synuclein
Poul Henning Jensen, Michael G. Schlossmacher, Leonidas Stefanis
Movement Disorders (2023) Vol. 38, Iss. 3, pp. 378-384
Open Access | Times Cited: 20
Controversial Properties of Amyloidogenic Proteins and Peptides: New Data in the COVID Era
Andrei Surguchov, Fatemeh Nouri Emamzadeh, Mariya Titova, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1215-1215
Open Access | Times Cited: 19
Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells
Fiona Limanaqi, Silvia Zecchini, Irma Saulle, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 7
Gastrointestinal Immunity and Alpha-Synuclein
Denise Barbut, Ethan D. Stolzenberg, Michael Zasloff
Journal of Parkinson s Disease (2019) Vol. 9, Iss. s2, pp. S313-S322
Open Access | Times Cited: 50
Alpha-synuclein supports type 1 interferon signalling in neurons and brain tissue
Brendan Monogue, Yixi Chen, Hadrian Sparks, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3622-3636
Open Access | Times Cited: 25
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Structural and functional conservation of non-lumenized lymphatic endothelial cells in the mammalian leptomeninges
Shannon Shibata-Germanos, James R. Goodman, Alan Grieg, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 2, pp. 383-401
Open Access | Times Cited: 38
Reovirus uses macropinocytosis-mediated entry and fast axonal transport to infect neurons
Pavithra Aravamudhan, Krishnan Raghunathan, Jennifer L. Konopka‐Anstadt, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 2, pp. e1008380-e1008380
Open Access | Times Cited: 34
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
Jean-Louis Parmasad, Konrad M. Ricke, Benjamin Nguyen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson’s disease
Dunhui Li, Wai Yan Yau, Shengdi Chen, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Evaluation of Carnosine Intervention in the Thy1-aSyn Mouse Model of Parkinson's Disease
Mei-Ling Bermúdez, Kim B. Seroogy, Mary Beth Genter
Neuroscience (2019) Vol. 411, pp. 270-278
Open Access | Times Cited: 31
Exploring human-genome gut-microbiome interaction in Parkinson’s disease
Zachary D. Wallen, William J. Stone, Stewart A. Factor, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 27
Dual role of the nasal microbiota in neurological diseases—An unignorable risk factor or a potential therapy carrier
Jin Xie, Shimin Tian, Jun Liu, et al.
Pharmacological Research (2022) Vol. 179, pp. 106189-106189
Closed Access | Times Cited: 18
Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
Gabriela Mercado, Christopher Kaeufer, Franziska Richter, et al.
Journal of Parkinson s Disease (2024), pp. 1-29
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top